Ling Wong, Ph.D.

The founder and general partner at Highbury Group, Ling Wong joined Lightspeed as a senior advisor where she leads investments in health and technology companies. Her career started in science as the creator of the world’s first inhaled TB vaccine while she was at Harvard. She worked for the Gates Foundation and helped establish its $1.5 billion global investment portfolio.